issued
on 29 Oct 2024
Last Applicant/ Owned by
6 / F,W Unit,Bldg.3,No.105 Jinghai 3 Rd.
Beijing
CN
100176
Serial Number
98284531 filed on 24th Nov 2023
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Bacterial poisons; Bacteriological culture mediums; Cell growth media for growing cells for medical or clinical use; Cytostatics for pharmaceutical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medicinal use; Enzyme preparations for med Read More
Bacterial poisons; Bacteriological culture mediums; Cell growth media for growing cells for medical or clinical use; Cytostatics for pharmaceutical purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic media for bacteriological cultures; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medicinal use; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Genetic identity tests comprised of reagents for medical purposes; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Preparations for detecting mutation in prion genes for medical purposes; Protein arrays for medical diagnosis purposes; Veterinary diagnostic reagents
N/A
N/A
No 98284531
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
29th Oct 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
03rd Sep 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
03rd Sep 2024 | PUBLISHED FOR OPPOSITION |
14th Aug 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Aug 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
30th Jul 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
29th Jul 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
29th Jul 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
25th Jun 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
25th Jun 2024 | NON-FINAL ACTION E-MAILED |